RUBIN PAUL D bought BIOA
January 2, 2026 · Form 4 insider transaction
RUBIN PAUL D bought 2,000 shares of BioAge Labs, Inc. at $6.57 per share, a transaction worth $13.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,000
Price
$6.57
Total value
$13.1K
InsiderRUBIN PAUL D
RoleOfficer
CompanyBioAge Labs, Inc. (BIOA)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 2, 2026
Filing dateJanuary 6, 2026
Shares owned after7,433
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024.